Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-05

Clinical Trial Update: Rezum FIM Optimization Study [NA]

View source ↗

Summary

Completed clinical trial (Rezum FIM Optimization Study) for benign prostatic hyperplasia with results posted in 2021.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rezum

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Benign Prostatic Hyperplasia, Adenoma, Prostatic | NA | Status: COMPLETED | Results posted: 2021-03-05